Toggle navigation
About
About The ASCO Post
Editorial Board
Rights and Permissions
Contact
Subscribe
News
FDA Update
Journal Spotlight
Expert's Corner
In the Clinic
View By Issue
View All
Meetings
2025 ASTRO Annual Meeting
2025 Debates and Didactics in Hematology and Oncology
IASLC WCLC 2025
SOHO 2025
22nd ASBrS Annual Meeting
Calendar
View All
Topics
Breast Cancer
Lung Cancer
Prostate Cancer
Lymphoma
Cardio-oncology
View All
Videos
Newsreels
Video Roundtables
Podcasts
Subscribe
Advertisement
Advertisement
NCCN 2018 Annual Conference,NCCN 2018 Annual Conference
«
1
»
Advertisement
Advertisement
Oct
05
Today In Oncology
Impact of Proton and Photon Therapy on HRQOL in Breast Cancer
Older Women With High-Risk Breast Cancer Addition of Adjuvant Chemotherapy to Hormone Therapy
Study Shows That After Early Breast Cancer Diagnosis, Risk of a Second Cancer is Low
Advanced or Metastatic Breast Cancer: FDA Approves Imlunestrant for ER-Positive, HER2-Negative, ESR1-Mutated Disease
Use of Obecabtagene Autoleucel CAR T-Cell Therapy for B-Cell Acute Lymphocytic Leukemia
View More
Advertisement
